Browsing Cancer Therapeutics by author "Bridgeman, Victoria"
Now showing items 1-1 of 1
-
Preclinical Evidence That Trametinib Enhances the Response to Antiangiogenic Tyrosine Kinase Inhibitors in Renal Cell Carcinoma.
Bridgeman, VL; Wan, E; Foo, S; Nathan, MR; Welti, JC; et al. (AMER ASSOC CANCER RESEARCH, 2016-01-01)Sunitinib and pazopanib are antiangiogenic tyrosine kinase inhibitors (TKI) used to treat metastatic renal cell carcinoma (RCC). However, the ability of these drugs to extend progression-free and overall survival in this ...